Pharmacodynamic functions : a multiparameter approach to the design of antibiotic treatment regimens
There is a complex quantitative relationship between the concentrations of antibiotics and the growth and death rates of bacteria. Despite this complexity, in most cases only a single pharmacodynamic parameter, the MIC of the drug, is employed for the rational development of antibiotic treatment regimens. In this report, we use a mathematical model based on a Hill function-which we call the pharmacodynamic function and which is related to previously published E(max) models-to describe the relationship between the bacterial net growth rates and the concentrations of antibiotics of five different classes: ampicillin, ciprofloxacin, tetracycline, streptomycin, and rifampin. Using Escherichia coli O18:K1:H7, we illustrate how precise estimates of the four parameters of the pharmacodynamic function can be obtained from in vitro time-kill data. We show that, in addition to their respective MICs, these antibiotics differ in the values of the other pharmacodynamic parameters. Using a computer simulation of antibiotic treatment in vivo, we demonstrate that, as a consequence of differences in pharmacodynamic parameters, such as the steepness of the Hill function and the minimum bacterial net growth rate attained at high antibiotic concentrations, there can be profound differences in the microbiological efficacy of antibiotics with identical MICs. We discuss the clinical implications and limitations of these results.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2004 |
---|---|
Erschienen: |
2004 |
Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
---|---|
Enthalten in: |
Antimicrobial agents and chemotherapy - 48(2004), 10 vom: 04. Okt., Seite 3670-6 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Regoes, Roland R [VerfasserIn] |
---|
Themen: |
Anti-Bacterial Agents |
---|
Anmerkungen: |
Date Completed 29.11.2004 Date Revised 18.03.2022 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM150624093 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM150624093 | ||
003 | DE-627 | ||
005 | 20231223054236.0 | ||
007 | tu | ||
008 | 231223s2004 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0502.xml |
035 | |a (DE-627)NLM150624093 | ||
035 | |a (NLM)15388418 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Regoes, Roland R |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pharmacodynamic functions |b a multiparameter approach to the design of antibiotic treatment regimens |
264 | 1 | |c 2004 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 29.11.2004 | ||
500 | |a Date Revised 18.03.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a There is a complex quantitative relationship between the concentrations of antibiotics and the growth and death rates of bacteria. Despite this complexity, in most cases only a single pharmacodynamic parameter, the MIC of the drug, is employed for the rational development of antibiotic treatment regimens. In this report, we use a mathematical model based on a Hill function-which we call the pharmacodynamic function and which is related to previously published E(max) models-to describe the relationship between the bacterial net growth rates and the concentrations of antibiotics of five different classes: ampicillin, ciprofloxacin, tetracycline, streptomycin, and rifampin. Using Escherichia coli O18:K1:H7, we illustrate how precise estimates of the four parameters of the pharmacodynamic function can be obtained from in vitro time-kill data. We show that, in addition to their respective MICs, these antibiotics differ in the values of the other pharmacodynamic parameters. Using a computer simulation of antibiotic treatment in vivo, we demonstrate that, as a consequence of differences in pharmacodynamic parameters, such as the steepness of the Hill function and the minimum bacterial net growth rate attained at high antibiotic concentrations, there can be profound differences in the microbiological efficacy of antibiotics with identical MICs. We discuss the clinical implications and limitations of these results | ||
650 | 4 | |a Comparative Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Research Support, U.S. Gov't, P.H.S. | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
700 | 1 | |a Wiuff, Camilla |e verfasserin |4 aut | |
700 | 1 | |a Zappala, Renata M |e verfasserin |4 aut | |
700 | 1 | |a Garner, Kim N |e verfasserin |4 aut | |
700 | 1 | |a Baquero, Fernando |e verfasserin |4 aut | |
700 | 1 | |a Levin, Bruce R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Antimicrobial agents and chemotherapy |d 1972 |g 48(2004), 10 vom: 04. Okt., Seite 3670-6 |w (DE-627)NLM000026506 |x 1098-6596 |7 nnns |
773 | 1 | 8 | |g volume:48 |g year:2004 |g number:10 |g day:04 |g month:10 |g pages:3670-6 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 48 |j 2004 |e 10 |b 04 |c 10 |h 3670-6 |